Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Zactran
1. 145435-72-9
2. Ml-1709460
3. Ml-1,709,460
4. Ml-460
5. Ze856183s0
6. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-11-(((2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-7-propyl-1-oxa-7-azacyclopentadecan-15-one
7. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-7-propyl-1-oxa-7-azacyclopentadecan-15-one
8. Gamithromycin [usan:inn]
9. Unii-ze856183s0
10. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8
11. Gamithromycin [mi]
12. Gamithromycin [inn]
13. Gamithromycin [usan]
14. Chembl2107342
15. Dtxsid90904260
16. Gamithromycin [green Book]
17. Ex-a1349
18. Mfcd09954125
19. S5328
20. Zinc169292837
21. Cs-7858
22. Db11416
23. Ds-4441
24. Gamithromycin 100 Microg/ml In Methanol
25. Ac-32611
26. Gamithromycin [ema Epar Veterinary]
27. Hy-108365
28. C72760
29. 435g729
30. A884620
31. J-008105
32. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-13-((2,6-dideoxy-3-c-methyl-3-o-methyl-.alpha.-l-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-((3,4,6-trideoxy-3-(dimethylamino)-.beta.-d-xylo-hexopyranosyl)oxy)-1-oxa-7-azacyclopentadecan-15-one
33. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-13-[(2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyl)
34. (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-13-[(2,6-dideoxy-3-cmethyl-3-o-methyl-a-l-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-d-xylo-hexopyranosyl]oxy]-1-oxa-7-azacyclopentadecan-15-one
35. 1-oxa-7-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-c-methyl-3-o-methyl-.alpha.-l-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-((3,4,6-trideoxy-3-(dimethylamino)-.beta.-d-xylo-hexopyranosyl)oxy)-, (2r,3s,4r,5s,8r,10r,11r,12s,13s,14r)-
36. 1-oxa-7-azacyclopentadecan-15-one,13-[(2,6-dideoxy-3-c-methyl-3-o-methyl-a-l-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-d-xylo-hexopyranosyl]oxy]-,[2r-(2r*,3s*,4r*,5s*,8r*,10r*,11r*,12s*,13s*,14r*)]-
| Molecular Weight | 777.0 g/mol |
|---|---|
| Molecular Formula | C40H76N2O12 |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 9 |
| Exact Mass | 776.53982586 g/mol |
| Monoisotopic Mass | 776.53982586 g/mol |
| Topological Polar Surface Area | 180 Ų |
| Heavy Atom Count | 54 |
| Formal Charge | 0 |
| Complexity | 1180 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
* Cattle:
Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. The presence of the disease in the herd should be established before metaphylactic use.
* Pigs:
Treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Bordetella bronchiseptica.
* Sheep:
Treatment of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus and Fusobacterium necrophorum requiring systemic treatment.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
QJ01FA95
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
Regulatory Info :
Registration Country : Canada
Brand Name : ZACTRAN
Dosage Form : SOLUTION
Dosage Strength : 150MG/ML
Packaging : 100/250/500ML
Approval Date :
Application Number : 2347407
Regulatory Info :
Registration Country : Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Sterilized Injection
Dosage Strength : 15%
Packaging : 50ml/100ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 50ml/100ml
Regulatory Info :
Dosage : Sterilized Injection
Dosage Strength : 15%
Brand Name :
Approval Date :
Application Number :
Registration Country : China
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Market Place
Patents & EXCLUSIVITIES
Health Canada Patents
Patent Expiration Date : 2019-07-07
Date Granted : 2009-06-23
Brand Name : ZACTRAN
Patent Number : 2336809
Filing Date : 1999-07-07
Strength per Unit : 150 mg/mL
Dosage Form : Injectable Solution
Human Or VET : Veterinary
Route of Administration : Subcutaneous
Patent Expiration Date : 2019-07-07
Date Granted : 2009-06-23
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Gamithromycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gamithromycin, including repackagers and relabelers. The FDA regulates Gamithromycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gamithromycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gamithromycin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gamithromycin supplier is an individual or a company that provides Gamithromycin active pharmaceutical ingredient (API) or Gamithromycin finished formulations upon request. The Gamithromycin suppliers may include Gamithromycin API manufacturers, exporters, distributors and traders.
click here to find a list of Gamithromycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Gamithromycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gamithromycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gamithromycin GMP manufacturer or Gamithromycin GMP API supplier for your needs.
A Gamithromycin CoA (Certificate of Analysis) is a formal document that attests to Gamithromycin's compliance with Gamithromycin specifications and serves as a tool for batch-level quality control.
Gamithromycin CoA mostly includes findings from lab analyses of a specific batch. For each Gamithromycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gamithromycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Gamithromycin EP), Gamithromycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gamithromycin USP).
LOOKING FOR A SUPPLIER?
